The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ASRT | -27.67% | -71.39% | -22.14% | -95% |
| S&P | +19.61% | +98.99% | +14.75% | +605% |
Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
The company rewarded investors with good news today.
The company announced full-year 2017 earnings yesterday after the market closed.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $29.22M | -6.1% |
| Gross Profit | $9.28M | -40.2% |
| Gross Margin | 31.75% | -18.1% |
| Market Cap | $61.41M | -47.9% |
| Market Cap / Employee | $1.06M | 0.0% |
| Employees | 58 | 9.4% |
| Net Income | -$16.35M | -345.1% |
| EBITDA | $1.23M | -75.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $47.09M | 5.3% |
| Accounts Receivable | $61.09M | 53.1% |
| Inventory | 32.9 | -15.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $45.52M | 13.8% |
| Short Term Debt | $0.27M | -60.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -15.65% | 85.2% |
| Return On Invested Capital | -36.94% | 10.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $19.09M | 158.4% |
| Operating Free Cash Flow | $19.09M | 158.4% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.86 | 0.64 | 0.53 | 0.57 | -35.48% |
| Price to Sales | 0.89 | 0.67 | 0.54 | 0.53 | -41.18% |
| Price to Tangible Book Value | 2.95 | 2.18 | 1.59 | 1.65 | -59.80% |
| Price to Free Cash Flow TTM | 5.50 | 3.15 | 10.15 | 3.41 | -33.43% |
| Enterprise Value to EBITDA | 18.59 | -11.20 | -6.25 | 7.41 | -47.40% |
| Free Cash Flow Yield | 18.2% | 31.7% | 9.9% | 29.4% | 50.22% |
| Return on Equity | -42.4% | -16.7% | -25.2% | -38.4% | -78.50% |
| Total Debt | $49.75M | $40.27M | $45.77M | $45.79M | 12.64% |
ASRT earnings call for the period ending June 30, 2019.
ASRT earnings call for the period ending March 31, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
